Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma Breast

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Ruben D Carrasco

Validating the eCyPA/CD147 signaling complex for myeloma therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Nikhil C Munshi

Integrative Oncogenomics of Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Catriona HM Jamieson

(PQC2) Niche-responsive RNA editing by ADAR1 in dormant multiple myeloma initiating cell maintenance

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Robert L Comis

ECOG-ACRIN Operations Center

Trachea, bronchus and lung Prostate Pancreas Non-Hodgkin lymphoma Nasopharynx Multiple myeloma and immunoproliferative diseases Melanoma of skin Leukaemia Colorectum Breast Bladder